This research report titled ‘Global Transcriptomics Market 2016-2020’ provides an in-depth analysis of the market in terms of revenue and emerging market trends. This market research report also includes up to date analysis and forecasts for various market segments and all geographical regions.
|Increasing strategic initiatives among vendors worldwide to enhance their transcriptomics product offerings in different geographical regions has increased growth avenues. These initiatives are intended to improve product availability and affordability as well as enhance product features in some cases. For instance, Edico Genome entered into a partnership with IBM to hasten genome data analysis from hours to minutes.|
Request a sample report: http://www.technavio.com/request-a-sample?report=52496
Technavio’s sample reports are free of charge and contain multiple sections of the report including the market size and forecast, drivers, challenges, trends, and more.
Based on technology, the report categorizes the global transcriptomics market into the following segments:
Global transcriptomics market by technology 2015 (%)
Global transcriptomics market by PCR technology
“The PCR technique is popular among end-users due to its ability to make accurate and quick copies of a specific segment of DNA. It also allows investigators to obtain large quantities of DNA that are then used for numerous experiments and procedures in forensic analysis, evolutionary biology, molecular biology, and medical diagnostics,” says Amber Chourasia, a lead lab equipmentresearch analyst at Technavio.
PCR is available in different types, including standard RT-PCR, dPCR, and qPCR, and the technique has a number of applications in research and diagnostics, including evolution study, gene cloning, fossil studies, and vaccine development. RT-PCR provides high sensitivity and specificity in experiments, with low contamination risk and fast speed in amplification, compared with conventional PCR, leading to its increased usage in disease diagnosis and in clinical microbiology laboratories.
Global transcriptomics market by NGS technology
NGS is popular among pharmaceutical and biotechnology companies and diagnostic laboratories and allows targeted sequencing of a genome to identify alterations or abnormalities in genome sequences that cause diseases. It is valuable in targeted sequencing, whole-genome sequencing, noncoding RNA expression profiling, and discovery of transcription factor binding sites.
Illumina, a US based medical devices provider, holds more than 63% of the global NGS market.
The NGS technique is efficient compared with Sanger sequencing, which is a conventional sequencing technology. For example, NGS is capable of generating millions of sequences at a time, which is not possible with conventional techniques. This enables researchers to carry out whole genome sequencing of various organisms in comparative biology studies. “The market for NGS will grow at a steady rate due to increase in reading lengths of sample, facilitated by advanced technology, reduced costs, and faster sequencing from existing platforms,” affirms Amber.
Global transcriptomics market by RNAi technology
RNAi is a new transcriptomics technology that has transformed mammalian gene expression research. The technology has gained popularity in the recent years owing to its capability to quantitatively and qualitatively examine any RNA type, including microRNAs, messenger RNAs (mRNAs), long noncoding RNAs, and small interfering RNAs.
Generally, the technique involves gene silencing (a natural defense mechanism against viruses that acts as a system for gene regulation) to prevent the synthesis of a particular protein. Gene silencing techniques are used in clinical diagnosis and research to understand the functions of a specific gene and to analyze its role within a disease, and decide on effective treatments.
Global transcriptomics market by microarray technology
Microarrays have been extensively used for the profiling of gene expression in diverse developmental processes, treatments, and study of diseases. Microarray technology detects the copy-number variations responsible for many disorders such as genetic diseases or cancer. Microarrays are also used frequently in medical diagnostics and genomics-based research to detect abnormalities in genomic-sequence, or to examine the role of chromosomes or genes in a particular disease. Also, microarrays are extensively used in analyzing large mammalian transcriptomes, for instance in clinical research and drug development that require rapid assessment of specific genes in thousands of samples.
A major drawback of microarrays is that they can only detect known sequences due to which they cannot be used for investigations. However, microarrays can be used in a variety of applications such as diagnostic microbiology, including determination of antimicrobial resistance, detection and identification of pathogens, and epidemiological strain typing.
The top vendors highlighted by Technavio’s research analysts in this report are:
Browse Related Reports:
Do you need a report on a market in a specific geographical cluster or country but can’t find what you’re looking for? Don’t worry, Technavio also takes client requests. Please contact email@example.com with your requirements and our analysts will be happy to create a customized report just for you.
Technavio is a leading global technology research and advisory company. The company develops over 2000 pieces of research every year, covering more than 500 technologies across 80 countries. Technavio has about 300 analysts globally who specialize in customized consulting and business research assignments across the latest leading edge technologies.
Technavio analysts employ primary as well as secondary research techniques to ascertain the size and vendor landscape in a range of markets. Analysts obtain information using a combination of bottom-up and top-down approaches, besides using in-house market modeling tools and proprietary databases. They corroborate this data with the data obtained from various market participants and stakeholders across the value chain, including vendors, service providers, distributors, re-sellers, and end-users.
If you are interested in more information, please contact our media team at firstname.lastname@example.org.
View source version on businesswire.com: http://www.businesswire.com/news/home/20161003005802/en/Business Wire
Last updated on: 03/10/2016
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.